Merck: FDA won’t accept its application for combo cholesterol pill including Pfizer’s Lipitor

FDA won’t accept Merck’s application for new drug

Drugmaker Merck for first time discloses payments to doctors who give talks to colleagues

Merck starts revealing payments to doctor-speakers

TRENTON, N.J. — Merck & Co. paid doctors and nurses a total of $3.7 million this summer to give talks to colleagues about the drugmaker’s products and other health topics, Merck disclosed Monday.

Drugmaker Sanofi-Aventis buys Merck’s half of Merial; step needed for Merck to buy Schering

Sanofi buys Merck’s half of animal health business

TRENTON, N.J. — French drugmaker Sanofi-Aventis SA has completed its $4 billion purchase of Merck & Co.’s half interest in their veterinary medicine business, Merial Ltd., the companies said Friday.

Drugmaker Merck, British research charity to develop vaccines for diseases in poor countries

Merck, British charity to jointly develop vaccines

TRENTON, N.J. — Drugmaker Merck & Co. and Britain’s largest charity, the Wellcome Trust, said Thursday they are starting a not-for-profit partnership to create affordable vaccines against diseases common in poor countries.